NITRO-BID Drug Patent Profile
✉ Email this page to a colleague
When do Nitro-bid patents expire, and when can generic versions of Nitro-bid launch?
Nitro-bid is a drug marketed by Sanofi Aventis Us and is included in two NDAs.
The generic ingredient in NITRO-BID is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nitro-bid
A generic version of NITRO-BID was approved as nitroglycerin by AM REGENT on May 24th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NITRO-BID?
- What are the global sales for NITRO-BID?
- What is Average Wholesale Price for NITRO-BID?
Summary for NITRO-BID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Patent Applications: | 2,143 |
| Drug Prices: | Drug price information for NITRO-BID |
| Drug Sales Revenues: | Drug sales revenues for NITRO-BID |
| DailyMed Link: | NITRO-BID at DailyMed |
US Patents and Regulatory Information for NITRO-BID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | NITRO-BID | nitroglycerin | INJECTABLE;INJECTION | 018621-001 | Jan 5, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sanofi Aventis Us | NITRO-BID | nitroglycerin | INJECTABLE;INJECTION | 071159-001 | Feb 28, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
